Danaher Corporation announced a quarterly cash dividend of $0.40 per share, payable on July 31, 2026, to shareholders recorded by June 26, 2026. This dividend reflects Danaher's ongoing commitment to returning value to shareholders. As a leading life sciences and diagnostics company, Danaher continues to focus on innovation and operational excellence to improve health outcomes globally. Investors can expect this steady dividend as part of Danaher's financial strategy moving forward.
The global Rapid Medical Diagnostic Kits market, valued at $28.11 billion in 2025, is projected to grow to $67 billion by 2035 at a CAGR of 9.06%. Growth is fueled by increasing infectious and chronic diseases, technological innovations like AI and b...
Halper Sadeh LLC is investigating whether certain officers and directors of Danaher Corporation breached their fiduciary duties to shareholders. Long-term Danaher stockholders may be eligible to seek corporate governance reforms, financial incentives...
The global molecular biology enzymes, reagents, and kits market is projected to grow from $27.69 billion in 2025 to $70.85 billion by 2035, at a CAGR of 9.68%. Growth is fueled by rising use of molecular diagnostics, genomics research, and precision ...
